Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effects of combinations of antileukemic agents on an acute lymphocytic leukemia of mice.

Literature DB >> 13009674

Effects of combinations of antileukemic agents on an acute lymphocytic leukemia of mice.

L W LAW.

Abstract

Entities: Disease Species

Keywords: LEUKEMIA, LYMPHATIC/experimental

Mesh：

Substances：
Antineoplastic Agents

Year: 1952 PMID： 13009674

Source DB: PubMed Journal: Cancer Res ISSN： 0008-5472 Impact factor: 12.701

Keyword Cloud
Cited

× No keyword cloud information.

18 in total

1. The chemical control of cancer.

Authors: J F HOLLAND
Journal: Public Health Rep Date: 1954-12 Impact factor: 2.792

2. Use of big data in drug development for precision medicine.

Authors: Rosa S Kim; Nicolas Goossens; Yujin Hoshida
Journal: Expert Rev Precis Med Drug Dev Date: 2016-04-28

Review 3. Understanding resistance to combination chemotherapy.

Authors: Justin R Pritchard; Douglas A Lauffenburger; Michael T Hemann
Journal: Drug Resist Updat Date: 2012-11-17 Impact factor: 18.500

4. Defining principles of combination drug mechanisms of action.

Authors: Justin R Pritchard; Peter M Bruno; Luke A Gilbert; Kelsey L Capron; Douglas A Lauffenburger; Michael T Hemann
Journal: Proc Natl Acad Sci U S A Date: 2012-12-18 Impact factor: 11.205

Review 5. Challenges and opportunities in childhood cancer drug development.

Authors: Robin E Norris; Peter C Adamson
Journal: Nat Rev Cancer Date: 2012-10-11 Impact factor: 60.716

6. A curative combination cancer therapy achieves high fractional cell killing through low cross-resistance and drug additivity.

Authors: Adam C Palmer; Christopher Chidley; Peter K Sorger
Journal: Elife Date: 2019-11-19 Impact factor: 8.140

Effects of combinations of antileukemic agents on an acute lymphocytic leukemia of mice.

1. The chemical control of cancer.

2. Use of big data in drug development for precision medicine.

Review 3. Understanding resistance to combination chemotherapy.

4. Defining principles of combination drug mechanisms of action.

Review 5. Challenges and opportunities in childhood cancer drug development.

6. A curative combination cancer therapy achieves high fractional cell killing through low cross-resistance and drug additivity.

7. Effect of ribonucleotide reductase inhibitors on the growth of human colon carcinoma HT-29 cells in culture.

8. Addressing genetic tumor heterogeneity through computationally predictive combination therapy.

Review 9. Modeling Tumor Clonal Evolution for Drug Combinations Design.

10. Combination Cancer Therapy Can Confer Benefit via Patient-to-Patient Variability without Drug Additivity or Synergy.